Overview

Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
Depomed's Gabapentin Extended Release is an investigational, extended release formulation of Gabapentin that is being studied for the treatment of Hot Flashes/Hot Flushes in postmenopausal women
Phase:
Phase 3
Details
Lead Sponsor:
Depomed
Treatments:
Gabapentin
gamma-Aminobutyric Acid